CAI 8-K 2026-11-04

Caris Life Sciences, Inc. (CAI) 8-K dated 2026-11-04 — accession 0002019410-26-000067.

Caris Life Sciences, Inc. (CAI) is a biotechnology company listed on NASDAQ.

Caris Life Sciences, Inc. filed a 8-K on 2026-11-04. Accession 0002019410-26-000067.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.

Not investment advice. The CAI SEC hub lists recent forms. The stock page is the research view.